New migraine medications could endanger patients with high blood pressure

da Salute H24 — 26 novembre 2019 alle 10:48

The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. Continua »


Scrivi un commento